Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors

Oncotarget(2021)10.18632/oncotarget.27988Source: DataRank Database

Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors is a research paper published in Oncotarget (2021). On theSindex it has a DataRank of 0. It has been cited 74 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access74 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (9)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Min Gyu Lee ORCID,Shilpa S. Dhar

Live enrichment

PubMed:34194626 PMC:PMC8238240

NCI NIH HHS

Grant: R01 CA207098

NCI NIH HHS

Grant: R01 CA207109

National Institutes of Health

Grant: 1R01CA207098-01A1

Role of the Histone Modifier KDM2A in Lung Cancer

National Institutes of Health

Grant: 5R01CA207109-04

Role of the Histone Methyltransferase MLL4 in Medulloblastoma

goldLicense: CC BY

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.27988

Europe_PMChttps://europepmc.org/articles/PMC8238240

Europe_PMChttps://europepmc.org/articles/PMC8238240?pdf=render

https://doi.org/10.18632/oncotarget.27988

https://www.oncotarget.com/article/27988/pdf/

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

CancerEpigeneticshistone methyltransferaseKmt2dMll4Review

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 2 of Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma

10.6084/m9.figshare.19669967.v1figshare

Additional file 2 of Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma

10.6084/m9.figshare.19669967figshare

Additional file 1 of Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma

10.6084/m9.figshare.19669964.v1figshare

Additional file 1 of Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma

10.6084/m9.figshare.19669964figshare

Additional file 2 of Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes

10.6084/m9.figshare.26571463figshare

Additional file 2 of Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes

10.6084/m9.figshare.26571463.v1figshare

Additional file 1 of Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes

10.6084/m9.figshare.26571460.v1figshare

Additional file 1 of Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes

10.6084/m9.figshare.26571460figshare